{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:31:12Z","timestamp":1794447072672,"version":"4.9.1"},"reference-count":136,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMIR"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Radio-frequency ablation (RFA) and Stereotactic Body Radiation Therapy\n(SBRT) are two emerging therapies for lung metastases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p> Aliterature review was performed to evaluate the outcomes and complications of these\nprocedures in patients with lung metastases from soft tissue sarcoma (STS).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>After selection, seven studies were included for each treatment encompassing a total of\n424 patients: 218 in the SBRT group and 206 in the RFA group.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The mean age ranged from 47.9 to 64 years in the SBRT group and from 48 to 62.7 years\nin the RFA group. The most common histologic subtype was, in both groups, leiomyosarcoma.\nIn the SBRT group, median overall survival ranged from 25.2 to 69 months and median disease-\nfree interval was from 8.4 to 45 months. Two out of seven studies reported G3 and one G3\ntoxicity, respectively. In RFA patients, overall survival ranged from 15 to 50 months. The most frequent\ncomplication was pneumothorax. Local control showed a high percentage for both procedures.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>SBRT is recommended in patients unsuitable to surgery, in synchronous bilateral pulmonary\nmetastases, in case of deep lesions and patients receiving high-risk systemic therapies.\nRFA is indicated in case of a long disease-free interval, in oligometastatic disease, when only the\nlung is involved, in small size lesions far from large vessels.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Further large randomized studies are necessary to establish whether these treatments may also represent\na reliable alternative to surgery.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573405616999200819165709","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T18:29:17Z","timestamp":1598466557000},"page":"261-275","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Non-surgical Treatments for Lung Metastases in Patients with Soft Tissue Sarcoma: Stereotactic Body Radiation Therapy (SBRT) and Radiofrequency Ablation (RFA)"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6428-5592","authenticated-orcid":true,"given":"Cecilia","family":"Tetta","sequence":"first","affiliation":[{"name":"Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, Bologna,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5406-8014","authenticated-orcid":true,"given":"Maria","family":"Carpenzano","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute Maastricht - CARIM, Maastricht University Medical Center, Maastricht,Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-2018","authenticated-orcid":true,"given":"Areej T.J.","family":"Algargoush","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute Maastricht - CARIM, Maastricht University Medical Center, Maastricht,Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-5776","authenticated-orcid":true,"given":"Marwah","family":"Algargoosh","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute Maastricht - CARIM, Maastricht University Medical Center, Maastricht,Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8955-6053","authenticated-orcid":true,"given":"Francesco","family":"Londero","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute Maastricht - CARIM, Maastricht University Medical Center, Maastricht,Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3230-7712","authenticated-orcid":true,"given":"Jos G.","family":"Maessen","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute Maastricht - CARIM, Maastricht University Medical Center, Maastricht,Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7746-989X","authenticated-orcid":true,"given":"Sandro","family":"Gelsomino","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute Maastricht - CARIM, Maastricht University Medical Center, Maastricht,Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"Jemal A.","year":"2007","unstructured":"Jemal A.; Siegel R.; Ward E.; Murray T.; Xu J.; Thun M.J.; Cancer statistics, 2007. CA Cancer J Clin 2007,57(1),43-66","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/cncr.28657","volume":"120","author":"Doyle L.A.","year":"2014","unstructured":"Doyle L.A.; Sarcoma classification: An update based on the 2013 World Health Organization classification of tumors of soft tissue and bone. Cancer 2014,120(12),1763-1774","journal-title":"Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0011-3840(96)80013-X","volume":"33","author":"Lewis J.J.","year":"1996","unstructured":"Lewis J.J.; Brennan M.F.; Soft tissue sarcomas. Curr Probl Surg 1996,33(10),817-872","journal-title":"Curr Probl Surg"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/1097-0142(20010515)91:10<1914:AID-CNCR1214>3.0.CO;2-3","volume":"91","author":"Coindre J.M.","year":"2001","unstructured":"Coindre J.M.; Terrier P.; Guillou L.; Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001,91(10),1914-1926","journal-title":"Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/cncr.25538","volume":"117","author":"Italiano A.","year":"2011","unstructured":"Italiano A.; Mathoulin-Pelissier S.; Cesne A.L.; Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer 2011,117(5),1049-1054","journal-title":"Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/archsurg.1983.01390080023007","volume":"118","author":"Vezeridis M.P.","year":"1983","unstructured":"Vezeridis M.P.; Moore R.; Karakousis C.P.; Metastatic patterns in soft-tissue sarcomas. Arch Surg 1983,118(8),915-918","journal-title":"Arch Surg"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<675:AID-CNCR13>3.0.CO;2-Y","volume":"77","author":"van Geel A.N.","year":"1996","unstructured":"van Geel A.N.; Pastorino U.; Jauch K.W.; Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer 1996,77(4),675-682","journal-title":"Cancer"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/archsurg.142.1.70","volume":"142","author":"Rehders A.","year":"2007","unstructured":"Rehders A.; Hosch S.B.; Scheunemann P.; Stoecklein N.H.; Knoefel W.T.; Peiper M.; Benefit of surgical treatment of lung metastasis in soft tissue sarcoma. Arch Surg 2007,142(1),70-75","journal-title":"Arch Surg"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.soc.2016.05.005","volume":"25","author":"Digesu C.S.","year":"2016","unstructured":"Digesu C.S.; Wiesel O.; Vaporciyan A.A.; Colson Y.L.; Management of sarcoma metastases to the lung. Surg Oncol Clin N Am 2016,25(4),721-733","journal-title":"Surg Oncol Clin N Am"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0022-5223(19)34514-3","volume":"97","author":"Jablons D.","year":"1989","unstructured":"Jablons D.; Steinberg S.M.; Roth J.; Pittaluga S.; Rosenberg S.A.; Pass H.I.; Metastasectomy for soft tissue sarcoma. Further evidence for efficacy and prognostic indicators. J Thorac Cardiovasc Surg 1989,97(5),695-705","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11864-002-0069-1","volume":"3","author":"Abdalla E.K.","year":"2002","unstructured":"Abdalla E.K.; Pisters P.W.; Metastasectomy for limited metastases from soft tissue sarcoma. Curr Treat Options Oncol 2002,3(6),497-505","journal-title":"Curr Treat Options Oncol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3109\/17453679509002316","volume":"66","author":"Choong P.F.","year":"1995","unstructured":"Choong P.F.; Pritchard D.J.; Rock M.G.; Sim F.H.; Frassica F.J.; Survival after pulmonary metastasectomy in soft tissue sarcoma. Prognostic factors in 214 patients. Acta Orthop Scand 1995,66(6),561-568","journal-title":"Acta Orthop Scand"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1055\/s-0035-1546430","volume":"64","author":"Okiror L.","year":"2016","unstructured":"Okiror L.; Peleki A.; Moffat D.; Survival following pulmonary metastasectomy for sarcoma. Thorac Cardiovasc Surg 2016,64(2),146-149","journal-title":"Thorac Cardiovasc Surg"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/00000658-199312000-00002","volume":"218","author":"Gadd M.A.","year":"1993","unstructured":"Gadd M.A.; Casper E.S.; Woodruff J.M.; McCormack P.M.; Brennan M.F.; Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg 1993,218(6),705-712","journal-title":"Ann Surg"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1001\/archsurg.1986.01400110034005","volume":"121","author":"Rizzoni W.E.","year":"1986","unstructured":"Rizzoni W.E.; Pass H.I.; Wesley M.N.; Rosenberg S.A.; Roth J.A.; Resection of recurrent pulmonary metastases in patients with soft-tissue sarcomas. Arch Surg 1986,121(11),1248-1252","journal-title":"Arch Surg"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0889-8588(18)30076-5","volume":"9","author":"Putnam J.B.","year":"1995","unstructured":"Putnam J.B.; Roth J.A.; Surgical treatment for pulmonary metastases from sarcoma. Hematol Oncol Clin North Am 1995,9(4),869-887","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.thorsurg.2007.03.007","volume":"17","author":"Abbas G.","year":"2007","unstructured":"Abbas G.; Schuchert M.J.; Pennathur A.; Gilbert S.; Luketich J.D.; Ablative treatments for lung tumors: radiofrequency ablation, stereotactic radiosurgery, and microwave ablation. Thorac Surg Clin 2007,17(2),261-271","journal-title":"Thorac Surg Clin"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"S259","DOI":"10.1148\/radiographics.22.suppl_1.g02oc03s259","volume":"22","author":"Dupuy D.E.","year":"2002","unstructured":"Dupuy D.E.; Mayo-Smith W.W.; Abbott G.F.; DiPetrillo T.; Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 2002,22(Spec No),S259-S269","journal-title":"Radiographics"},{"key":"ref=19","first-page":"12","volume":"19","author":"Suh R.","year":"2005","unstructured":"Suh R.; Reckamp K.; Zeidler M.; Cameron R.; Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology (Williston Park) 2005,19(Suppl. 4),12-21","journal-title":"Oncology (Williston Park)"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1590\/S1806-37132015000000034","volume":"41","author":"Abreu C.E.C.V.","year":"2015","unstructured":"Abreu C.E.C.V.; Ferreira P.P.R.; de Moraes F.Y.; Neves W.F.P.; Gadia R.; Carvalho HdA. Stereotactic body radiotherapy in lung cancer: an update. J Bras Pneumol 2015,41(4),376-387","journal-title":"J Bras Pneumol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejca.2018.02.017","volume":"94","author":"de Baere T.","year":"2018","unstructured":"de Baere T.; Tselikas L.; Gravel G.; Interventional radiology: Role in the treatment of sarcomas. Eur J Cancer 2018,94,148-155","journal-title":"Eur J Cancer"},{"key":"ref=22","first-page":"287","volume":"65","author":"Hiraki T.","year":"2011","unstructured":"Hiraki T.; Gobara H.; Mimura H.; Radiofrequency ablation of lung cancer at Okayama University Hospital: a review of 10 years of experience. Acta Med Okayama 2011,65(5),287-297","journal-title":"Acta Med Okayama"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3748\/wjg.v20.i4.988","volume":"20","author":"Hiraki T.","year":"2014","unstructured":"Hiraki T.; Gobara H.; Iguchi T.; Fujiwara H.; Matsui Y.; Kanazawa S.; Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancer. World J Gastroenterol 2014,20(4),988-996","journal-title":"World J Gastroenterol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"Moher D.","year":"2009","unstructured":"Moher D.; Liberati A.; Tetzlaff J.; Altman D.G.; Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009,339,b2535","journal-title":"BMJ"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/jso.24268","volume":"114","author":"Baumann B.C.","year":"2016","unstructured":"Baumann B.C.; Nagda S.N.; Kolker J.D.; Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection. J Surg Oncol 2016,114(1),65-69","journal-title":"J Surg Oncol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01243894-200610000-00008","volume":"1","author":"Le Q.T.","year":"2006","unstructured":"Le Q.T.; Loo B.W.; Ho A.; Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006,1(8),802-809","journal-title":"J Thorac Oncol"},{"key":"ref=27","first-page":"316","volume":"102","author":"Leksell L.","year":"1951","unstructured":"Leksell L.; The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951,102(4),316-319","journal-title":"Acta Chir Scand"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3109\/02841869509127197","volume":"34","author":"Blomgren H.","year":"1995","unstructured":"Blomgren H.; Lax I.; N\u00e4slund I.; Svanstr\u00f6m R.; Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995,34(6),861-870","journal-title":"Acta Oncol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/107327480801500202","volume":"15","author":"Dilling T.J.","year":"2008","unstructured":"Dilling T.J.; Hoffe S.E.; Stereotactic body radiation therapy: transcending the conventional to improve outcomes. Cancer Contr 2008,15(2),104-111","journal-title":"Cancer Contr"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1016\/j.ijrobp.2006.08.018","volume":"66","author":"Schefter T.E.","year":"2006","unstructured":"Schefter T.E.; Kavanagh B.D.; Raben D.; A phase I\/II trial of stereotactic body radiation therapy (SBRT) for lung metastases: Initial report of dose escalation and early toxicity. Int J Radiat Oncol Biol Phys 2006,66(4),S120-S127","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ejca.2015.01.061","volume":"51","author":"Navarria P.","year":"2015","unstructured":"Navarria P.; Ascolese A.M.; Cozzi L.; Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. Eur J Cancer 2015,51(5),668-674","journal-title":"Eur J Cancer"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/JTO.0b013e3181de7143","volume":"5","author":"Siva S.","year":"2010","unstructured":"Siva S.; MacManus M.; Ball D.; Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol 2010,5(7),1091-1099","journal-title":"J Thorac Oncol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","volume":"24","author":"Timmerman R.","year":"2006","unstructured":"Timmerman R.; McGarry R.; Yiannoutsos C.; Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006,24(30),4833-4839","journal-title":"J Clin Oncol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ssu.10032","volume":"21","author":"Mac Manus M.P.","year":"2003","unstructured":"Mac Manus M.P.; Hicks R.J.; PET scanning in lung cancer: current status and future directions. Semin Surg Oncol 2003,21(3),149-155","journal-title":"Semin Surg Oncol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ijrobp.2009.02.051","volume":"76","author":"Henderson M.A.","year":"2010","unstructured":"Henderson M.A.; Hoopes D.J.; Fletcher J.W.; A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010,76(3),789-795","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.kjms.2014.07.001","volume":"30","author":"Kuo Y.H.","year":"2014","unstructured":"Kuo Y.H.; Chung K.C.; Hung C.H.; Lu S.N.; Wang J.H.; The impact of general anesthesia on radiofrequency ablation of hepatocellular carcinoma. Kaohsiung J Med Sci 2014,30(11),559-565","journal-title":"Kaohsiung J Med Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1213\/01.ane.0000239053.40982.0f","volume":"103","author":"Hanazaki M.","year":"2006","unstructured":"Hanazaki M.; Taga N.; Nakatsuka H.; Anesthetic management of radiofrequency ablation of mediastinal metastatic lymph nodes adjacent to the trachea. Anesth Analg 2006,103(4),1041-1042","journal-title":"Anesth Analg"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13063-018-3010-z","volume":"20","author":"Pan J.","year":"2019","unstructured":"Pan J.; Li X.; He Y.; \n            Comparison of dexmedetomidine \n            \n              vs.\n            \n            remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial.\n           Trials 2019,20(1),28","journal-title":"Trials"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.soc.2016.02.008","volume":"25","author":"Abbas G.","year":"2016","unstructured":"Abbas G.; Danish A.; Krasna M.J.; Stereotactic body radiotherapy and ablative therapies for lung cancer. Surg Oncol Clin N Am 2016,25(3),553-566","journal-title":"Surg Oncol Clin N Am"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/s-0033-1342955","volume":"30","author":"Alexander E.S.","year":"2013","unstructured":"Alexander E.S.; Dupuy D.E.; Lung cancer ablation: technologies and techniques. Semin Intervent Radiol 2013,30(2),141-150","journal-title":"Semin Intervent Radiol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1148\/radiol.2303021801","volume":"230","author":"Ahmed M.","year":"2004","unstructured":"Ahmed M.; Liu Z.; Afzal K.S.; Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 2004,230(3),761-767","journal-title":"Radiology"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1102\/1470-7330.2011.9033","volume":"11","author":"Rasmussen F.","year":"2011","unstructured":"Rasmussen F.; Madsen H.H.T.; Imaging follow-up of RF ablation of lung tumours. Cancer Imaging 2011,11(1A),S123-S128","journal-title":"Cancer Imaging"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3816\/CLC.2004.n.027","volume":"6","author":"Fernando H.C.","year":"2004","unstructured":"Fernando H.C.; Hoyos A.D.; Litle V.; Belani C.P.; Luketich J.D.; Radiofrequency ablation: identification of the ideal patient. Clin Lung Cancer 2004,6(3),149-153","journal-title":"Clin Lung Cancer"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1148\/radiol.2402050807","volume":"240","author":"de Ba\u00e8re T.","year":"2006","unstructured":"de Ba\u00e8re T.; Palussi\u00e8re J.; Aup\u00e9rin A.; Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 2006,240(2),587-596","journal-title":"Radiology"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1148\/rg.324105181","volume":"32","author":"Abtin F.G.","year":"2012","unstructured":"Abtin F.G.; Eradat J.; Gutierrez A.J.; Lee C.; Fishbein M.C.; Suh R.D.; Radiofrequency ablation of lung tumors: imaging features of the postablation zone. Radiographics 2012,32(4),947-969","journal-title":"Radiographics"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1148\/radiol.2301020934","volume":"230","author":"Lee J.M.","year":"2004","unstructured":"Lee J.M.; Jin G.Y.; Goldberg S.N.; Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004,230(1),125-134","journal-title":"Radiology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00270-008-9482-6","volume":"32","author":"Anderson E.M.","year":"2009","unstructured":"Anderson E.M.; Lees W.R.; Gillams A.R.; Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 2009,32(3),478-483","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref=48","first-page":"18137","volume":"8","author":"Wang Y.","year":"2015","unstructured":"Wang Y.; Li G.; Li W.; He X.; Xu L.; Radiofrequency ablation of advanced lung tumors: imaging features, local control, and follow-up protocol. Int J Clin Exp Med 2015,8(10),18137-18143","journal-title":"Int J Clin Exp Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1245\/s10434-011-1705-4","volume":"18","author":"Cho H.S.","year":"2011","unstructured":"Cho H.S.; Park I.H.; Jeong W.J.; Han I.; Kim H.S.; Prognostic value of computed tomography for monitoring pulmonary metastases in soft tissue sarcoma patients after surgical management: a retrospective cohort study. Ann Surg Oncol 2011,18(12),3392-3398","journal-title":"Ann Surg Oncol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"20140598","DOI":"10.1259\/bjr.20140598","volume":"88","author":"Smith S.L.","year":"2015","unstructured":"Smith S.L.; Jennings P.E.; Lung radiofrequency and microwave ablation: a review of indications, techniques and post-procedural imaging appearances. Br J Radiol 2015,88(1046),20140598","journal-title":"Br J Radiol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2214\/ajr.183.4.1831013","volume":"183","author":"Jin G.Y.","year":"2004","unstructured":"Jin G.Y.; Lee J.M.; Lee Y.C.; Han Y.M.; Lim Y.S.; Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol 2004,183(4),1013-1020","journal-title":"AJR Am J Roentgenol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s00270-011-0191-1","volume":"35","author":"Palussi\u00e8re J.","year":"2012","unstructured":"Palussi\u00e8re J.; G\u00f3mez F.; Cannella M.; Single-session radiofrequency ablation of bilateral lung metastases. Cardiovasc Intervent Radiol 2012,35(4),852-859","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00270-010-0048-z","volume":"34","author":"Palussi\u00e8re J.","year":"2011","unstructured":"Palussi\u00e8re J.; Marcet B.; Descat E.; Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Intervent Radiol 2011,34(5),989-997","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.ijrobp.2010.11.052","volume":"82","author":"Dhakal S.","year":"2012","unstructured":"Dhakal S.; Corbin K.S.; Milano M.T.; Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. Int J Radiat Oncol Biol Phys 2012,82(2),940-945","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s11547-018-0912-5","volume":"123","author":"Loi M.","year":"2018","unstructured":"Loi M.; Duijm M.; Baker S.; Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma. Radiol Med (Torino) 2018,123(11),871-878","journal-title":"Radiol Med (Torino)"},{"key":"ref=56","first-page":"5581","volume":"35","author":"Frakulli R.","year":"2015","unstructured":"Frakulli R.; Salvi F.; Balestrini D.; Stereotactic radiotherapy in the treatment of lung metastases from bone and soft-tissue sarcomas. Anticancer Res 2015,35(10),5581-5586","journal-title":"Anticancer Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/COC.0000000000000103","volume":"40","author":"Soyfer V.","year":"2017","unstructured":"Soyfer V.; Corn B.W.; Shtraus N.; Single-institution experience of SBRT for lung metastases in sarcoma patients. Am J Clin Oncol 2017,40(1),83-85","journal-title":"Am J Clin Oncol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1007\/s12032-012-0256-2","volume":"29","author":"Stragliotto C.L.","year":"2012","unstructured":"Stragliotto C.L.; Karlsson K.; Lax I.; A retrospective study of SBRT of metastases in patients with primary sarcoma. Med Oncol 2012,29(5),3431-3439","journal-title":"Med Oncol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1002\/cncr.24420","volume":"115","author":"Nakamura T.","year":"2009","unstructured":"Nakamura T.; Matsumine A.; Yamakado K.; Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas. Cancer [corrected2009,115(16),3774-3781","journal-title":"Cancer"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1245\/s10434-011-1806-0","volume":"18","author":"Palussi\u00e8re J.","year":"2011","unstructured":"Palussi\u00e8re J.; Italiano A.; Descat E.; Sarcoma lung metastases treated with percutaneous radiofrequency ablation: results from 29 patients. Ann Surg Oncol 2011,18(13),3771-3777","journal-title":"Ann Surg Oncol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4103\/0973-1482.113358","volume":"9","author":"Nakamura T.","year":"2013","unstructured":"Nakamura T.; Matsumine A.; Yamakado K.; Takao M.; Uchida A.; Sudo A.; Clinical significance of radiofrequency ablation and metastasectomy in elderly patients with lung metastases from musculoskeletal sarcomas. J Cancer Res Ther 2013,9(2),219-223","journal-title":"J Cancer Res Ther"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00270-013-0644-9","volume":"37","author":"Koelblinger C.","year":"2014","unstructured":"Koelblinger C.; Strauss S.; Gillams A.; Outcome after radiofrequency ablation of sarcoma lung metastases. Cardiovasc Intervent Radiol 2014,37(1),147-153","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2147\/OTT.S121562","volume":"10","author":"Nakamura T.","year":"2017","unstructured":"Nakamura T.; Matsumine A.; Takao M.; Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and\/or radiofrequency ablation of the lung. OncoTargets Ther 2017,10,559-564","journal-title":"OncoTargets Ther"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11604-016-0601-z","volume":"35","author":"Sato T.","year":"2017","unstructured":"Sato T.; Iguchi T.; Hiraki T.; Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients. Jpn J Radiol 2017,35(2),61-67","journal-title":"Jpn J Radiol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/annonc\/mdv037","volume":"26","author":"de Ba\u00e8re T.","year":"2015","unstructured":"de Ba\u00e8re T.; Aup\u00e9rin A.; Deschamps F.; Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 2015,26(5),987-991","journal-title":"Ann Oncol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/00000658-199905000-00002","volume":"229","author":"Billingsley K.G.","year":"1999","unstructured":"Billingsley K.G.; Burt M.E.; Jara E.; Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999,229(5),602-610","journal-title":"Ann Surg"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.athoracsur.2008.09.036","volume":"87","author":"Gossot D.","year":"2009","unstructured":"Gossot D.; Radu C.; Girard P.; Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach? Ann Thorac Surg 2009,87(1),238-243","journal-title":"Ann Thorac Surg"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1072-7515(00)00306-9","volume":"191","author":"Weiser M.R.","year":"2000","unstructured":"Weiser M.R.; Downey R.J.; Leung D.H.; Brennan M.F.; Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg 2000,191(2),184-190","journal-title":"J Am Coll Surg"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","volume":"15","author":"Judson I.","year":"2014","unstructured":"Judson I.; Verweij J.; Gelderblom H.; Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol 2014,15(4),415-423","journal-title":"Lancet Oncol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1200\/EDBK_157450","volume":"35","author":"Gronchi A.","year":"2016","unstructured":"Gronchi A.; Guadagnolo B.A.; Erinjeri J.P.; Local ablative therapies to metastatic soft tissue sarcoma. Am Soc Clin Oncol Educ Book 2016,35,e566-e575","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1200\/JCO.2008.21.0088","volume":"27","author":"Demetri G.D.","year":"2009","unstructured":"Demetri G.D.; Chawla S.P.; von Mehren M.; Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. J Clin Oncol 2009,27(25),4188-4196","journal-title":"J Clin Oncol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2005.10.003","volume":"32","author":"Mocellin S.","year":"2006","unstructured":"Mocellin S.; Rossi C.R.; Brandes A.; Nitti D.; Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches. Cancer Treat Rev 2006,32(1),9-27","journal-title":"Cancer Treat Rev"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/annonc\/mds607","volume":"24","author":"Santoro A.","year":"2013","unstructured":"Santoro A.; Comandone A.; Basso U.; Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy. Ann Oncol 2013,24(4),1093-1098","journal-title":"Ann Oncol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/annonc\/mdt586","volume":"25","author":"Kasper B.","year":"2014","unstructured":"Kasper B.; Sleijfer S.; Liti\u00e8re S.; Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072. Ann Oncol 2014,25(3),719-724","journal-title":"Ann Oncol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1590\/S1807-59322010000900010","volume":"65","author":"Sardenberg R.A.","year":"2010","unstructured":"Sardenberg R.A.; Figueiredo L.P.; Haddad F.J.; Gross J.L.; Younes R.N.; Pulmonary metastasectomy from soft tissue sarcomas. Clinics (S\u00e3o Paulo) 2010,65(9),871-876","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jtcvs.2017.02.061","volume":"154","author":"Chudgar N.P.","year":"2017","unstructured":"Chudgar N.P.; Brennan M.F.; Munhoz R.R.; Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma. J Thorac Cardiovasc Surg 2017,154(1),319-330","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"e001736","DOI":"10.1136\/bmjopen-2012-001736","volume":"2","author":"Treasure T.","year":"2012","unstructured":"Treasure T.; Fiorentino F.; Scarci M.; M\u00f8ller H.; Utley M.; Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data. BMJ Open 2012,2(5),e001736","journal-title":"BMJ Open"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.lungcan.2015.10.016","volume":"90","author":"Ricardi U.","year":"2015","unstructured":"Ricardi U.; Badellino S.; Filippi A.R.; Stereotactic body radiotherapy for early stage lung cancer: History and updated role. Lung Cancer 2015,90(3),388-396","journal-title":"Lung Cancer"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","volume":"81","author":"Onishi H.","year":"2011","unstructured":"Onishi H.; Shirato H.; Nagata Y.; Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011,81(5),1352-1358","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ijrobp.2005.01.002","volume":"62","author":"Schefter T.E.","year":"2005","unstructured":"Schefter T.E.; Kavanagh B.D.; Timmerman R.D.; Cardenes H.R.; Baron A.; Gaspar L.E.; A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005,62(5),1371-1378","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.ijrobp.2008.03.044","volume":"72","author":"Milano M.T.","year":"2008","unstructured":"Milano M.T.; Katz A.W.; Schell M.C.; Philip A.; Okunieff P.; Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2008,72(5),1516-1522","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ijrobp.2008.04.073","volume":"73","author":"Milano M.T.","year":"2009","unstructured":"Milano M.T.; Philip A.; Okunieff P.; Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses. Int J Radiat Oncol Biol Phys 2009,73(3),832-837","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/02841860600908954","volume":"45","author":"Okunieff P.","year":"2006","unstructured":"Okunieff P.; Petersen A.L.; Philip A.; Stereotactic Body Radiation Therapy (SBRT) for lung metastases. Acta Oncol 2006,45(7),808-817","journal-title":"Acta Oncol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3892\/ijo.2014.2295","volume":"44","author":"Yu W.","year":"2014","unstructured":"Yu W.; Tang L.; Lin F.; Stereotactic radiosurgery, a potential alternative treatment for pulmonary metastases from osteosarcoma. Int J Oncol 2014,44(4),1091-1098","journal-title":"Int J Oncol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"360214","DOI":"10.1155\/2013\/360214","volume":"2013","author":"Mehta N.","year":"2013","unstructured":"Mehta N.; Selch M.; Wang P.C.; Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma. Sarcoma 2013,2013,360214","journal-title":"Sarcoma"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"9132359","DOI":"10.1155\/2018\/9132359","volume":"2018","author":"Lindsay A.D.","year":"2018","unstructured":"Lindsay A.D.; Haupt E.E.; Chan C.M.; Treatment of sarcoma lung metastases with stereotactic body radiotherapy. Sarcoma 2018,2018,9132359","journal-title":"Sarcoma"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"927972","DOI":"10.1155\/2010\/927972","volume":"2010","author":"Soyfer V.","year":"2010","unstructured":"Soyfer V.; Corn B.W.; Kollender Y.; Tempelhoff H.; Meller I.; Merimsky O.; Radiation therapy for palliation of sarcoma metastases: a unique and uniform hypofractionation experience. Sarcoma 2010,2010,927972","journal-title":"Sarcoma"},{"key":"ref=88","first-page":"61","author":"Halperin E.C.","year":"2013","unstructured":"Halperin E.C.; Wazer D.E.; Brady L.W.; Perez C.A.;  Perez and Brady\u2019s principles and practice of radiation oncology 2013,61-88","journal-title":"Perez and Brady\u2019s principles and practice of radiation oncology"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1055\/s-0035-1563538","volume":"64","author":"Giuliano K.","year":"2016","unstructured":"Giuliano K.; Sachs T.; Montgomery E.; Survival following lung metastasectomy in soft tissue sarcomas. Thorac Cardiovasc Surg 2016,64(2),150-158","journal-title":"Thorac Cardiovasc Surg"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/JTO.0b013e3182106f5c","volume":"6","author":"Predina J.D.","year":"2011","unstructured":"Predina J.D.; Puc M.M.; Bergey M.R.; Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol 2011,6(5),913-919","journal-title":"J Thorac Oncol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/1759-7714.13160","volume":"10","author":"Chua G.W.Y.","year":"2019","unstructured":"Chua G.W.Y.; Chua K.L.M.; Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non-small cell lung cancer? An in-depth look at patient characteristics on both sides of the debate. Thorac Cancer 2019,10(10),1857-1867","journal-title":"Thorac Cancer"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","volume":"7","author":"Videtic G.M.M.","year":"2017","unstructured":"Videtic G.M.M.; Donington J.; Giuliani M.; Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol 2017,7(5),295-301","journal-title":"Pract Radiat Oncol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.6004\/jnccn.2012.0157","volume":"10","author":"Iyengar P.","year":"2012","unstructured":"Iyengar P.; Timmerman R.D.; Stereotactic ablative radiotherapy for non-small cell lung cancer: rationale and outcomes. J Natl Compr Canc Netw 2012,10(12),1514-1520","journal-title":"J Natl Compr Canc Netw"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.tranon.2019.04.015","volume":"12","author":"Dong B.","year":"2019","unstructured":"Dong B.; Wang J.; Xu Y.; Comparison of the efficacy of stereotactic body radiotherapy versus surgical treatment for early-stage non-small cell lung cancer after propensity score matching. Transl Oncol 2019,12(8),1032-1037","journal-title":"Transl Oncol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijrobp.2018.03.006","volume":"103","author":"Sahgal A.","year":"2019","unstructured":"Sahgal A.; Lead with surgery, SBRT to follow. Int J Radiat Oncol Biol Phys 2019,103(1),16-17","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2214\/ajr.174.1.1740057","volume":"174","author":"Dupuy D.E.","year":"2000","unstructured":"Dupuy D.E.; Zagoria R.J.; Akerley W.; Mayo-Smith W.W.; Kavanagh P.V.; Safran H.; Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000,174(1),57-59","journal-title":"AJR Am J Roentgenol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.semradonc.2017.03.003","volume":"27","author":"Siva S.","year":"2017","unstructured":"Siva S.; Slotman B.J.; Stereotactic ablative body radiotherapy for lung metastases: where is the evidence and what are we doing with it? Semin Radiat Oncol 2017,27(3),229-239","journal-title":"Semin Radiat Oncol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.radonc.2013.05.024","volume":"107","author":"Widder J.","year":"2013","unstructured":"Widder J.; Klinkenberg T.J.; Ubbels J.F.; Wiegman E.M.; Groen H.J.; Langendijk J.A.; Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? Radiother Oncol 2013,107(3),409-413","journal-title":"Radiother Oncol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1200\/JCO.2017.75.6536","volume":"36","author":"Stokes W.A.","year":"2018","unstructured":"Stokes W.A.; Bronsert M.R.; Meguid R.A.; Post-treatment mortality after surgery and stereotactic body radiotherapy for early-stage non-small-cell lung cancer. J Clin Oncol 2018,36(7),642-651","journal-title":"J Clin Oncol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jvir.2014.11.013","volume":"26","author":"Matsui Y.","year":"2015","unstructured":"Matsui Y.; Hiraki T.; Gobara H.; Long-term survival following percutaneous radiofrequency ablation of colorectal lung metastases. J Vasc Interv Radiol 2015,26(3),303-310","journal-title":"J Vasc Interv Radiol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1148\/radiol.2293021756","volume":"229","author":"Suh R.D.","year":"2003","unstructured":"Suh R.D.; Wallace A.B.; Sheehan R.E.; Heinze S.B.; Goldin J.G.; Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results. Radiology 2003,229(3),821-829","journal-title":"Radiology"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/01.RVI.0000126812.12853.77","volume":"15","author":"Akeboshi M.","year":"2004","unstructured":"Akeboshi M.; Yamakado K.; Nakatsuka A.; Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004,15(5),463-470","journal-title":"J Vasc Interv Radiol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1245\/ASO.2004.04.008","volume":"11","author":"Steinke K.","year":"2004","unstructured":"Steinke K.; Glenn D.; King J.; Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 2004,11(2),207-212","journal-title":"Ann Surg Oncol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1055\/s-0030-1261787","volume":"27","author":"Howenstein M.J.","year":"2010","unstructured":"Howenstein M.J.; Sato K.T.; Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms. Semin Intervent Radiol 2010,27(3),285-295","journal-title":"Semin Intervent Radiol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1148\/radiol.2313030347","volume":"231","author":"Yasui K.","year":"2004","unstructured":"Yasui K.; Kanazawa S.; Sano Y.; Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 2004,231(3),850-857","journal-title":"Radiology"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejcts.2006.03.067","volume":"30","author":"Ambrogi M.C.","year":"2006","unstructured":"Ambrogi M.C.; Lucchi M.; Dini P.; Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg 2006,30(1),177-183","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1007\/s00464-005-0607-6","volume":"20","author":"Lagan\u00e0 D.","year":"2006","unstructured":"Lagan\u00e0 D.; Carrafiello G.; Mangini M.; Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device. Surg Endosc 2006,20(8),1262-1267","journal-title":"Surg Endosc"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jvir.2014.08.027","volume":"25","author":"Ahmed M.","year":"2014","unstructured":"Ahmed M.; Solbiati L.; Brace C.L.; International Working Group on Image-Guided Tumor Ablation; Interventional Oncology Sans Fronti\u00e8res Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. J Vasc Interv Radiol 2014,25(11),1691-1705","journal-title":"J Vasc Interv Radiol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"S223","DOI":"10.1016\/j.jvir.2010.01.049","volume":"21","author":"Pua B.B.","year":"2010","unstructured":"Pua B.B.; Thornton R.H.; Solomon S.B.; Ablation of pulmonary malignancy: current status. J Vasc Interv Radiol 2010,21(Suppl. 8),S223-S232","journal-title":"J Vasc Interv Radiol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00330-007-0811-y","volume":"18","author":"Gillams A.R.","year":"2008","unstructured":"Gillams A.R.; Lees W.R.; Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol 2008,18(4),672-677","journal-title":"Eur Radiol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/JTO.0b013e3182208e58","volume":"6","author":"Casiraghi M.","year":"2011","unstructured":"Casiraghi M.; De Pas T.; Maisonneuve P.; A 10-year single-center experience on 708 lung metastasectomies: the evidence of the \u201cinternational registry of lung metastases\u201d. J Thorac Oncol 2011,6(8),1373-1378","journal-title":"J Thorac Oncol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.2930400414","volume":"40","author":"Pastorino U.","year":"1989","unstructured":"Pastorino U.; Valente M.; Gasparini M.; Lung resection for metastatic sarcomas: total survival from primary treatment. J Surg Oncol 1989,40(4),275-280","journal-title":"J Surg Oncol"},{"key":"ref=113","first-page":"2897","volume":"27","author":"Liebl L.S.","year":"2007","unstructured":"Liebl L.S.; Elson F.; Quaas A.; Gawad K.A.; Izbicki J.R.; Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma. Anticancer Res 2007,27(4C),2897-2902","journal-title":"Anticancer Res"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejso.2008.01.004","volume":"35","author":"Smith R.","year":"2009","unstructured":"Smith R.; Pak Y.; Kraybill W.; Kane J.M.; Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol 2009,35(4),356-361","journal-title":"Eur J Surg Oncol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2214\/AJR.17.18527","volume":"209","author":"Kurup A.N.","year":"2017","unstructured":"Kurup A.N.; Morris J.M.; Callstrom M.R.; Ablation of musculoskeletal metastases. AJR Am J Roentgenol 2017,209(4),713-721","journal-title":"AJR Am J Roentgenol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ejso.2009.12.005","volume":"36","author":"Jones R.L.","year":"2010","unstructured":"Jones R.L.; McCall J.; Adam A.; Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma. Eur J Surg Oncol 2010,36(5),477-482","journal-title":"Eur J Surg Oncol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.clon.2015.03.009","volume":"27","author":"Falk A.T.","year":"2015","unstructured":"Falk A.T.; Thyss A.; Thariat J.; Metastatic ablation for sarcomas: methodological and ethical dilemmas for prospective studies. Clin Oncol (R Coll Radiol) 2015,27(7),429-430","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.ejcts.2009.11.026","volume":"37","author":"Garc\u00eda Franco C.E.","year":"2010","unstructured":"Garc\u00eda Franco C.E.; Torre W.; Tamura A.; Long-term results after resection for bone sarcoma pulmonary metastases. Eur J Cardiothorac Surg 2010,37(5),1205-1208","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1007\/s00595-016-1312-x","volume":"46","author":"Hamaji M.","year":"2016","unstructured":"Hamaji M.; Chen F.; Miyamoto E.; Surgical and non-surgical management of repeat pulmonary metastasis from sarcoma following first pulmonary metastasectomy. Surg Today 2016,46(11),1296-1300","journal-title":"Surg Today"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1200\/EdBook_AM.2013.33.457","volume":"33","author":"Hohenberger P.","year":"2013","unstructured":"Hohenberger P.; Kasper B.; Ahrar K.; Surgical management and minimally invasive approaches for the treatment of metastatic sarcoma. Am Soc Clin Oncol Educ Book 2013,33,457-464","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10147-013-0640-8","volume":"19","author":"Yamakado K.","year":"2014","unstructured":"Yamakado K.; Matsumine A.; Nakamura T.; Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates. Int J Clin Oncol 2014,19(5),955-962","journal-title":"Int J Clin Oncol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0218492312462710","volume":"21","author":"Toussi M.S.","year":"2013","unstructured":"Toussi M.S.; Bagheri R.; Dayani M.; Anvari K.; Sheibani S.; Pulmonary metastasectomy and repeat metastasectomy for soft-tissue sarcoma. Asian Cardiovasc Thorac Ann 2013,21(4),437-442","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"W576-80","DOI":"10.2214\/AJR.11.6408","volume":"197","author":"Kashima M.","year":"2011","unstructured":"Kashima M.; Yamakado K.; Takaki H.; Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center\u2019s experiences. AJR Am J Roentgenol 2011,197(4),W576-80","journal-title":"AJR Am J Roentgenol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1148\/radiol.2411051087","volume":"241","author":"Hiraki T.","year":"2006","unstructured":"Hiraki T.; Tajiri N.; Mimura H.; Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 2006,241(1),275-283","journal-title":"Radiology"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11547-011-0741-2","volume":"117","author":"Carrafiello G.","year":"2012","unstructured":"Carrafiello G.; Mangini M.; Fontana F.; Complications of microwave and radiofrequency lung ablation: personal experience and review of the literature. Radiol Med (Torino) 2012,117(2),201-213","journal-title":"Radiol Med (Torino)"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1470-2045(08)70155-4","volume":"9","author":"Lencioni R.","year":"2008","unstructured":"Lencioni R.; Crocetti L.; Cioni R.; Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008,9(7),621-628","journal-title":"Lancet Oncol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0033-1342957","volume":"30","author":"Chheang S.","year":"2013","unstructured":"Chheang S.; Abtin F.; Guteirrez A.; Genshaft S.; Suh R.; Imaging features following thermal ablation of lung malignancies. Semin Intervent Radiol 2013,30(2),157-168","journal-title":"Semin Intervent Radiol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejca.2017.01.010","volume":"75","author":"de Baere T.","year":"2017","unstructured":"de Baere T.; Tselikas L.; Yevich S.; The role of image-guided therapy in the management of colorectal cancer metastatic disease. Eur J Cancer 2017,75,231-242","journal-title":"Eur J Cancer"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jvir.2009.09.028","volume":"21","author":"Sakurai J.","year":"2010","unstructured":"Sakurai J.; Hiraki T.; Mimura H.; Radiofrequency ablation of small lung metastases by a single application of a 2-cm expandable electrode: determination of favorable responders. J Vasc Interv Radiol 2010,21(2),231-236","journal-title":"J Vasc Interv Radiol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jvir.2008.12.411","volume":"20","author":"Hiraki T.","year":"2009","unstructured":"Hiraki T.; Mimura H.; Gobara H.; Two cases of needle-tract seeding after percutaneous radiofrequency ablation for lung cancer. J Vasc Interv Radiol 2009,20(3),415-418","journal-title":"J Vasc Interv Radiol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-0033-1342956","volume":"30","author":"de Baere T.","year":"2013","unstructured":"de Baere T.; Farouil G.; Deschamps F.; Lung cancer ablation: what is the evidence? Semin Intervent Radiol 2013,30(2),151-156","journal-title":"Semin Intervent Radiol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"S1420","DOI":"10.21037\/jtd.2019.02.94","volume":"11","author":"Matsuo Y.","year":"2019","unstructured":"Matsuo Y.; Stereotactic body radiotherapy as an alternative to metastasectomy for pulmonary oligometastasis. J Thorac Dis 2019,11(Suppl. 9),S1420-S1422","journal-title":"J Thorac Dis"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/02656736.2019.1647358","volume":"36","author":"Prud\u2019homme C.","year":"2019","unstructured":"Prud\u2019homme C.; Deschamps F.; Moulin B.; Image-guided lung metastasis ablation: a literature review. Int J Hyperthermia 2019,36(2),37-45","journal-title":"Int J Hyperthermia"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ejso.2008.07.015","volume":"35","author":"Chen F.","year":"2009","unstructured":"Chen F.; Fujinaga T.; Sato K.; Significance of tumor recurrence before pulmonary metastasis in pulmonary metastasectomy for soft tissue sarcoma. Eur J Surg Oncol 2009,35(6),660-665","journal-title":"Eur J Surg Oncol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jvir.2011.02.028","volume":"22","author":"de Baere T.","year":"2011","unstructured":"de Baere T.; Robinson J.M.; Rao P.; Teriitehau C.; Deschamps F.; Radiofrequency ablation of lung metastases close to large vessels during vascular occlusion: preliminary experience. J Vasc Interv Radiol 2011,22(6),749-754","journal-title":"J Vasc Interv Radiol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.semtcvs.2014.09.003","volume":"26","author":"Quirk M.T.","year":"2014","unstructured":"Quirk M.T.; Pomykala K.L.; Suh R.D.; Current readings: Percutaneous ablation for pulmonary metastatic disease. Semin Thorac Cardiovasc Surg 2014,26(3),239-248","journal-title":"Semin Thorac Cardiovasc Surg"}],"container-title":["Current Medical Imaging Formerly Current Medical Imaging Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573405616999200819165709","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/185110\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573405616999200819165709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T19:32:23Z","timestamp":1659900743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/185110\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573405616999200819165709","relation":{},"ISSN":["1573-4056"],"issn-type":[{"value":"1573-4056","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}